Subacute Sclerosing Panencephalitis: The Foothold in Undervaccination

Area of Science:

• Neurology
• Infectious Diseases
• Pediatrics

Background:

• Subacute sclerosing panencephalitis (SSPE) is a rare, fatal neurological complication following measles virus infection.
• Measles vaccination significantly reduces SSPE incidence, making cases in vaccinated individuals particularly noteworthy.
• Early diagnosis of SSPE is crucial but often challenging due to its varied and non-specific initial presentation.

Observation:

• A 3-year-old boy, fully vaccinated against measles, presented with symptoms initially suggestive of autoimmune encephalitis.
• The patient underwent treatment for presumed autoimmune encephalitis.
• Diagnostic workup eventually led to the identification of subacute sclerosing panencephalitis (SSPE).

Findings:

• This case underscores the potential for SSPE to occur in vaccinated children.
• The clinical presentation mimicked autoimmune encephalitis, complicating the diagnostic pathway.
• Delayed diagnosis of SSPE can occur, especially in developed countries with low endemic measles rates.

Implications:

• Healthcare providers in developed nations must maintain a high index of suspicion for SSPE, even in vaccinated populations.
• Diagnostic algorithms for suspected autoimmune encephalitis should consider SSPE as a differential diagnosis.
• Further research may be needed to understand the nuances of SSPE presentation and diagnosis in the context of widespread vaccination.